A new clinical study published in the International Journal of Gynecological Cancer reports encouraging results for women ...

Ian C. Cook, MD, discusses the feasibility and benefits of adding bilateral salpingectomy to nongynecologic surgery.

Women who received Elenagen plus chemotherapy lived significantly longer than those who received chemotherapy alone.

A retrospective study compared progression-free and overall survival of hyperthermic intraperitoneal chemotherapy with conventional intraperitoneal chemotherapy in patients with ovarian cancer.

A panelist discusses how National Comprehensive Cancer Network (NCCN) guidelines have influenced molecular testing in ovarian cancer, highlighting the importance of biomarkers like BRCA genes for ...

The biotech will explore the potential of BI-1808 plus Keytruda in clear cell and high-grade serous ovarian cancer subtypes.

The findings could one day pave the way for new adjunct therapies that support both treatment effectiveness and patient quality of life. Two compounds found in cannabis show potent anti-tumor effects ...

Ovarian cancer's history traces back to 1809 when Jane Todd Crawford, diagnosed with a massive ovarian tumor, underwent a risky surgery by Ephraim McDowell. McDowell, a frontier surgeon, performed the ...

In the future, scientists could use drugs made from cannabis to fight ovarian cancer. A team of scientists testing the ...

In this systematic review and meta-analysis, researchers examined outcomes among advanced ovarian cancer patients who ...